UB
RCUS icon

UMB Bank’s Arcus Biosciences RCUS Stock Holding History

UMB Bank’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Buy
555
+72
+15% +$1.55K ﹤0.01% 1792
2025
Q4 		$11.5K Buy
483
+101
+26% +$2.06K ﹤0.01% 1772
2025
Q3 		$5.2K Buy
382
+78
+26% +$811 ﹤0.01% 1871
2025
Q2 		$2.48K Buy
304
+160
+111% +$1.37K ﹤0.01% 1975
2025
Q1 		$1.13K Buy
144
+26
+22% +$301 ﹤0.01% 2026
2024
Q4 		$1.76K Sell
118
-17
-13% -$278 ﹤0.01% 1967
2024
Q3 		$2.06K Buy
135
+66
+96% +$1.04K ﹤0.01% 1979
2024
Q2 		$1.05K Buy
69
+47
+214% +$759 ﹤0.01% 1962
2024
Q1 		$415 Buy
+22
New +$380 ﹤0.01% 2023

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

UMB Bank's RCUS Position: Q1 2026 in Review

UMB Bank increased its Arcus Biosciences (RCUS) stake by 15% in Q1 2026, buying an estimated $1.55K and bringing the position to 555 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

UMB Bank first reported a position in RCUS in Q1 2024 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • UMB Bank held 555 shares of Arcus Biosciences worth $12K as of Q1 2026.
  • UMB Bank bought 72 Arcus Biosciences shares in Q1 2026, an estimated $1.55K.
  • Arcus Biosciences made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1792 holding.
  • UMB Bank first reported a position in Arcus Biosciences in Q1 2024 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.